The effect of axial length on photodynamic therapy

American Journal of Ophthalmology

Volumn 141, Issue 4, 2006, Pages

  Ansari Shahrezaei, Siamak ^a   Ergun, Erdem ^a   Stur, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EYE AXIS LENGTH; HYPERMETROPIA; LASER; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 33645312119     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.11.060     Document Type: Article

References (13)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of two randomized clinical trials-TAP Report 1 Arch Ophthalmol 117 1999 1329 1345
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin two-year results of two randomized clinical trials-TAP Report 2 Arch Ophthalmol 119 2001 198 207
3. Verteporfin in Photodynamic Therapy (VIP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin one-year results of a randomized clinical trial-VIP Report 1 Ophthalmology 108 2001 841 852
4. Verteporfin in Photodynamic Therapy (VIP) Study Group Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia two-year results of a randomized clinical trial-VIP Report 3 Ophthalmology 110 2003 667 673
5. Visudyne in Minimally Classic Choroidal Neovascularization (VIM) Study Group Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration two-year results of a randomized clinical trial Arch Ophthalmol 123 2005 448 457
6. U. Schmidt-Erfurth, J.W. Miller, M. Sickenberg Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration results of retreatments in a phase 1 and 2 study Arch Ophthalmol 117 1999 1177 1187
7. B. Rassow A model of Gullstrand's normal eye [in German] Ophthalmologica 164 1972 143 148
8. M. Stur, S. Ansari-Shahrezaei The effect of axial length on laser spot size and laser irradiance Arch Ophthalmol 119 2001 1323 1328
9. D.G. Altman, J.M. Bland Measurement in medicine the analysis of method comparison studies Statistician 32 1983 307 317
10. S.O. Ulvik, J.H. Seland, T. Wentzel-Larsen Refraction, axial length and age-related maculopathy Acta Ophthalmol Scand 83 2005 419 423
11. J. Wachtlin, T. Behme, H. Heimann Concentric retinal pigment epithelium atrophy after a single photodynamic therapy Graefes Arch Clin Exp Ophthalmol 241 2003 518 521
12. L. Postelmans, B. Pasteels, P. Coquelet Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females Am J Ophthalmol 138 2004 803 808
13. A.G. Bennett, A.R. Rudnicka, D.F. Edgar Improvements on Littmann's method of determining the size of retinal features by fundus photography Graefes Arch Clin Exp Ophthalmol 232 1994 361 367